Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Consumer Health
About Investor
Tom Woiwode, PhD is a Managing Director at Versant Ventures in San Francisco. He focuses on healthcare and life sciences, including biotech and therapeutics, as well as consumer health, health IT, and health and hospital services, typically at Seed and Series A. His investment range is $100K - $5.0M. His background blends investing with hands-on company building, including serving as COO of Okairos through its acquisition by GSK and taking early operating roles at multiple biotech startups.
Previous investments
Bright Peak Therapeutics
90M |2024
110M |2021
35M |2020
Belharra Therapeutics
50M |2023
iECURE
65M |2022
50M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.